• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名2019冠状病毒病患者的横纹肌溶解症

Rhabdomyolysis in a Patient With Coronavirus Disease 2019.

作者信息

Mukherjee Aveek, Ghosh Raisa, Aftab Ghulam

机构信息

Internal Medicine, Rutgers Robert Wood Johnson Medical School/Saint Peter's University Hospital, New Brunswick, USA.

Pulmonary Medicine, Rutgers Robert Wood Johnson Medical School/Saint Peter's University Hospital, New Brunswick, USA.

出版信息

Cureus. 2020 Jul 1;12(7):e8956. doi: 10.7759/cureus.8956.

DOI:10.7759/cureus.8956
PMID:32642390
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7336592/
Abstract

Coronavirus disease 2019 has rapidly enveloped the world in a pandemic after emerging in Wuhan, China, in December 2019. We describe a 49-year-old man presenting with fever, cough, dyspnea, and myalgia diagnosed with coronavirus disease 2019 along with rhabdomyolysis and acute kidney injury. The creatine phosphokinase was elevated to 23,800 U/L before trending down to normal levels. Rapid identification and treatment with aggressive intravenous hydration and correction of electrolyte abnormalities remain key to successful management. In a pandemic, often atypical presentations of this new disease have to be considered as differentials for early diagnosis and treatment of life-threatening conditions.

摘要

2019年12月在中国武汉出现后,2019冠状病毒病迅速在全球范围内引发大流行。我们描述了一名49岁男性,他出现发热、咳嗽、呼吸困难和肌痛,被诊断为2019冠状病毒病,同时伴有横纹肌溶解和急性肾损伤。肌酸磷酸激酶在降至正常水平之前升至23,800 U/L。快速识别并积极进行静脉补液治疗以及纠正电解质异常仍然是成功治疗的关键。在大流行期间,这种新疾病的非典型表现常常必须被视为危及生命状况的早期诊断和治疗的鉴别诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7336592/ca47fe782138/cureus-0012-00000008956-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7336592/756ab7540c0f/cureus-0012-00000008956-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7336592/ca47fe782138/cureus-0012-00000008956-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7336592/756ab7540c0f/cureus-0012-00000008956-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7336592/ca47fe782138/cureus-0012-00000008956-i02.jpg

相似文献

1
Rhabdomyolysis in a Patient With Coronavirus Disease 2019.一名2019冠状病毒病患者的横纹肌溶解症
Cureus. 2020 Jul 1;12(7):e8956. doi: 10.7759/cureus.8956.
2
A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine.一名使用羟氯喹治疗的新型冠状病毒肺炎(COVID-19)多灶性肺炎患者。
Cureus. 2020 Mar 30;12(3):e7473. doi: 10.7759/cureus.7473.
3
Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease.横纹肌溶解症作为2019年新型冠状病毒病的一种表现形式
Cureus. 2020 Apr 6;12(4):e7561. doi: 10.7759/cureus.7561.
4
A comparison of COVID-19, SARS and MERS.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的比较。
PeerJ. 2020 Aug 19;8:e9725. doi: 10.7717/peerj.9725. eCollection 2020.
5
Rhabdomyolysis after COVID-19 Infection: A Case Report and Review of the Literature.COVID-19 感染后横纹肌溶解症:病例报告及文献复习。
Viruses. 2022 Oct 14;14(10):2255. doi: 10.3390/v14102255.
6
A Rare Presentation of Coronavirus Disease 2019 (COVID-19) Induced Viral Myositis With Subsequent Rhabdomyolysis.2019冠状病毒病(COVID-19)引发的病毒性肌炎伴横纹肌溶解症的罕见病例
Cureus. 2020 May 12;12(5):e8074. doi: 10.7759/cureus.8074.
7
Asymptomatic Rhabdomyolysis in a Young Adult With COVID-19.一名新冠肺炎年轻成人患者的无症状性横纹肌溶解症
Cureus. 2021 Sep 17;13(9):e18039. doi: 10.7759/cureus.18039. eCollection 2021 Sep.
8
Rhabdomyolysis as the Initial Presentation of SARS-CoV-2 in an Adolescent.横纹肌溶解症作为 SARS-CoV-2 在青少年中的初始表现。
Pediatrics. 2021 Mar;147(3). doi: 10.1542/peds.2020-019273. Epub 2020 Oct 9.
9
Dark urine as the initial manifestation of COVID-19: a case report.以深色尿为首发表现的新型冠状病毒肺炎1例报告
J Med Case Rep. 2021 Dec 2;15(1):576. doi: 10.1186/s13256-021-03173-x.
10
Rhabdomyolysis in a patient with end-stage renal disease and SARS-CoV-2 infection: A case report.横纹肌溶解症合并终末期肾病及 SARS-CoV-2 感染患者:病例报告。
Medicine (Baltimore). 2023 Dec 1;102(48):e36360. doi: 10.1097/MD.0000000000036360.

引用本文的文献

1
Rhabdomyolysis secondary to COVID-19 infection and vaccination: a review of literature.新型冠状病毒肺炎感染及疫苗接种继发横纹肌溶解症:文献综述
Front Med (Lausanne). 2024 Nov 20;11:1460676. doi: 10.3389/fmed.2024.1460676. eCollection 2024.
2
Profound Rhabdomyolysis and Viral Myositis Due to SARS-CoV-2: A Case Report.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)所致的严重横纹肌溶解症和病毒性肌炎:一例报告
Cureus. 2024 May 27;16(5):e61172. doi: 10.7759/cureus.61172. eCollection 2024 May.
3
Blood flow restriction as a potential therapy to restore physical function following COVID-19 infection.

本文引用的文献

1
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.SARS-CoV、MERS-CoV 和 SARS-CoV-2 感染中的免疫致病反应和血液病理效应的重点。
Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020.
2
Acute Kidney Injury: From Diagnosis to Prevention and Treatment Strategies.急性肾损伤:从诊断到预防及治疗策略
J Clin Med. 2020 Jun 2;9(6):1704. doi: 10.3390/jcm9061704.
3
A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine.
血流限制作为一种潜在疗法,用于恢复新冠病毒感染后的身体功能。
Front Physiol. 2023 Jul 21;14:1235172. doi: 10.3389/fphys.2023.1235172. eCollection 2023.
4
The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection.轻度至中度新冠病毒感染后的肌肉骨骼受累情况
Front Physiol. 2022 Mar 18;13:813924. doi: 10.3389/fphys.2022.813924. eCollection 2022.
5
Unraveling Muscle Impairment Associated With COVID-19 and the Role of 3D Culture in Its Investigation.揭示与新冠病毒相关的肌肉损伤以及3D培养在其研究中的作用。
Front Nutr. 2022 Feb 10;9:825629. doi: 10.3389/fnut.2022.825629. eCollection 2022.
6
COVID-19 in CKD Patients: Report from India.慢性肾脏病患者中的新型冠状病毒肺炎:来自印度的报告。
Indian J Nephrol. 2021 Nov-Dec;31(6):524-530. doi: 10.4103/ijn.IJN_460_20. Epub 2021 Nov 9.
7
COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks.新型冠状病毒肺炎:新形成的病毒进化枝、病理生理学、治疗策略和当前疫苗接种任务综述。
Int J Biol Macromol. 2021 Dec 15;193(Pt B):1165-1200. doi: 10.1016/j.ijbiomac.2021.10.144. Epub 2021 Oct 25.
8
Hypophosphatemia at Admission is Associated with Increased Mortality in COVID-19 Patients.入院时低磷血症与COVID-19患者死亡率增加相关。
Int J Gen Med. 2021 Sep 7;14:5313-5322. doi: 10.2147/IJGM.S319717. eCollection 2021.
9
Screening for Sarcopenia (Physical Frailty) in the COVID-19 Era.2019冠状病毒病(COVID-19)时代的肌少症(身体虚弱)筛查
Int J Endocrinol. 2021 May 21;2021:5563960. doi: 10.1155/2021/5563960. eCollection 2021.
10
A review of Covid-19 and acute kidney injury: from pathophysiology to clinical results.Covid-19 与急性肾损伤:从病理生理学到临床结果的综述。
J Bras Nefrol. 2021 Oct-Dec;43(4):551-571. doi: 10.1590/2175-8239-JBN-2020-0204.
一名使用羟氯喹治疗的新型冠状病毒肺炎(COVID-19)多灶性肺炎患者。
Cureus. 2020 Mar 30;12(3):e7473. doi: 10.7759/cureus.7473.
4
Rhabdomyolysis as Potential Late Complication Associated with COVID-19.横纹肌溶解症作为与 COVID-19 相关的潜在迟发性并发症。
Emerg Infect Dis. 2020 Jul;26(7):1618-1620. doi: 10.3201/eid2607.200445. Epub 2020 Jun 21.
5
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
6
Benign acute viral myositis in African migrants: A clinical, serological, and pathological study.非洲移民中的良性急性病毒性肌炎:一项临床、血清学和病理学研究。
Muscle Nerve. 2019 Nov;60(5):586-590. doi: 10.1002/mus.26679. Epub 2019 Aug 30.
7
Rhabdomyolysis secondary to influenza a infection: a case report and review of the literature.甲型流感感染继发横纹肌溶解症:一例病例报告及文献复习
N Am J Med Sci. 2015 Mar;7(3):122-4. doi: 10.4103/1947-2714.153926.
8
Rhabdomyolysis: review of the literature.横纹肌溶解症:文献综述
Neuromuscul Disord. 2014 Aug;24(8):651-9. doi: 10.1016/j.nmd.2014.05.005. Epub 2014 May 21.
9
KDIGO clinical practice guidelines for acute kidney injury.改善全球肾脏病预后组织(KDIGO)急性肾损伤临床实践指南
Nephron Clin Pract. 2012;120(4):c179-84. doi: 10.1159/000339789. Epub 2012 Aug 7.
10
Rhabdomyolysis associated with 2009 influenza A(H1N1).与2009年甲型H1N1流感相关的横纹肌溶解症
JAMA. 2009 Nov 4;302(17):1863-4. doi: 10.1001/jama.2009.1582.